BLC
ELV icon

Brown, Lisle/Cummings’s Elevance Health ELV Stock Holding History

Brown, Lisle/Cummings’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.96K Sell
18
-1
-5% -$371 ﹤0.01% 658
2026
Q1 		$5.56K Buy
+19
New +$6.25K ﹤0.01% 659
2025
Q3 		– Sell
-8
Closed -$3.23K – 769
2025
Q2 		$3.23K Hold
8
– – ﹤0.01% 609
2025
Q1 		$3.48K Buy
+8
New +$3.21K ﹤0.01% 600

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brown, Lisle/Cummings's ELV Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Elevance Health (ELV) stake by 5.3% in Q2 2026, selling an estimated $371 and leaving 18 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Brown, Lisle/Cummings first reported a position in ELV in Q1 2025 and has held it in 4 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Brown, Lisle/Cummings held 18 shares of Elevance Health worth $6.96K as of Q2 2026.
  • Brown, Lisle/Cummings sold 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #658 holding.
  • Brown, Lisle/Cummings first reported a position in Elevance Health in Q1 2025 and has held it in 4 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.